Publications by authors named "Christos Vaklavas"

32Publications

Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer.

Transl Oncol 2020 Feb 3;13(2):452-470. Epub 2020 Jan 3.

Department of Pathology, O'Neal Comprehensive Cancer Centre, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2019.12.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948383PMC
February 2020

Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development.

Front Oncol 2017 26;7:158. Epub 2017 Jul 26.

Department of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2017.00158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526920PMC
July 2017

IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells.

Tumour Biol 2016 Oct 26;37(10):13247-13264. Epub 2016 Jul 26.

Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-016-5161-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097113PMC
October 2016

Small molecule inhibitors of IRES-mediated translation.

Cancer Biol Ther 2015 15;16(10):1471-85. Epub 2015 Jul 15.

a Comprehensive Cancer Center; University of Alabama at Birmingham ; Birmingham , AL USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2015.1071729DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846101PMC
September 2016

Management of metastatic breast cancer with second-generation antibody-drug conjugates: focus on glembatumumab vedotin (CDX-011, CR011-vcMMAE).

BioDrugs 2014 Jun;28(3):253-63

Division of Hematology/Clinical Oncology, Department of Medicine, Comprehensive Cancer Center, University of Alabama at Birmingham, NP 2540M, 1802 6th Avenue South, Birmingham, AL, 35294-3300, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40259-014-0085-2DOI Listing
June 2014

Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma.

Ther Adv Hematol 2012 Aug;3(4):209-25

Division of Hematology/Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/2040620712443076
Publisher Site
http://dx.doi.org/10.1177/2040620712443076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627331PMC
August 2012

A 62-year-old woman with osteogenic sarcoma in the contralateral breast 15 years after treatment for breast cancer.

Semin Oncol 2013 Apr;40(2):135-44

Department of Radiation Oncology, Regional Cancer Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.01.010DOI Listing
April 2013

Phase I study of a modified regimen of ⁹⁰Yttrium-ibritumomab tiuxetan for relapsed or refractory follicular or transformed CD20+ non-Hodgkin lymphoma.

Cancer Biother Radiopharm 2013 Jun 26;28(5):370-9. Epub 2013 Mar 26.

Department of Hematology and Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/cbr.2012.1387
Publisher Site
http://dx.doi.org/10.1089/cbr.2012.1387DOI Listing
June 2013

By the pricking of my thumbs, something wicked this way comes: sporadic cancers versus eponymous hereditary cancer predisposition syndromes.

J Natl Compr Canc Netw 2012 Jan;10(1):7-13

Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, 1530 Third Avenue South, Birmingham, AL 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2012.0004DOI Listing
January 2012

How do I treat "triple-negative" disease.

Curr Treat Options Oncol 2011 Dec;12(4):369-88

Comprehensive Cancer Center, University of Alabama at Birmingham, AL 35294-3300, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-011-0168-y
Publisher Site
http://dx.doi.org/10.1007/s11864-011-0168-yDOI Listing
December 2011

Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center.

Cancer 2012 Mar 5;118(5):1422-8. Epub 2011 Aug 5.

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26413DOI Listing
March 2012

A case of acute promyelocytic leukemia without RARα rearrangement and apparently normal cytogenetics.

Clin Lymphoma Myeloma Leuk 2011 Dec 19;11(6):521-4. Epub 2011 May 19.

Division of Hematology and Oncology, University of Alabama at Birmingham, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.03.036DOI Listing
December 2011

Common cardiovascular medications in cancer therapeutics.

Pharmacol Ther 2011 May 26;130(2):177-90. Epub 2011 Jan 26.

Phase 1 Program, Department of Investigational Cancer Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2011.01.009DOI Listing
May 2011

Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.

Virol J 2010 Sep 28;7:256. Epub 2010 Sep 28.

Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1743-422X-7-256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954859PMC
September 2010

Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience.

Cancer 2011 Jan 24;117(1):77-85. Epub 2010 Aug 24.

Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410640PMC
January 2011

Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias.

Clin Cancer Res 2010 Feb 9;16(4):1149-58. Epub 2010 Feb 9.

Division of Pediatrics, Departments of Leukemia and Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-2416DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988651PMC
February 2010

Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target?

Oncologist 2010 5;15(2):130-41. Epub 2010 Feb 5.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-0252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227935PMC
June 2010

Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experience.

J Clin Endocrinol Metab 2009 Nov 9;94(11):4423-32. Epub 2009 Oct 9.

Department of Investigational Cancer Therapeutics, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2009-0743DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775645PMC
November 2009

Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.

J Pediatr Hematol Oncol 2009 Nov;31(11):803-11

Division of Pediatrics, The University of Texas MD Anderson Cancer Center, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e3181ba43dcDOI Listing
November 2009

Molecular basis of statin-associated myopathy.

Atherosclerosis 2009 Jan 21;202(1):18-28. Epub 2008 May 21.

Department of Internal Medicine, University of Texas Medical School at Houston, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2008.05.021DOI Listing
January 2009